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The replicationof long tracts of telomeric repeatsmay require
specific factors to avoid fork regression (Fouché, N., Özgür, S.,
Roy, D., and Griffith, J. (2006)Nucleic Acids Res., in press). Here
we show that TRF2 binds to model replication forks and four-
way junctions in vitro in a structure-specific but sequence-inde-
pendent manner. A synthetic peptide encompassing the TRF2
basic domain alsobinds toDNAfour-way junctions,whereas the
TRF2 truncation mutant (TRF2B) and a mutant basic domain
peptide do not. In the absence of the basic domain, the ability of
TRF2 to localize to model telomere ends and facilitate t-loop
formation in vitro is diminished. We propose that TRF2 plays a
key role during telomere replication in binding chickenfoot
intermediates of telomere replication fork regression. Junction-
specific bindingwould also allowTRF2 to stabilize a strand inva-
sion structure that is thought to exist at the strand invasion site
of the t-loop.
Telomeres are nucleoprotein structures that protect the ends
of chromosomes and are essential for regulating the replicative
lifespan of somatic cells. The DNA component of the mamma-
lian telomere consists of long double-stranded (ds)2 tracts of
the hexameric repeat unit TTAGGG (2) that endswith aG-rich
3 single-stranded (ss) overhang (3). Telomeric DNA is thought
to be organized into a t-loop “end-capping” structure by the
telomere-binding proteinsTRF1, TRF2, andPOT1 and the pro-
teins that bind to them, TIN2, TPP1, and Rap1 (4, 5). This
higher order structure may enable cells to distinguish chro-
mosome ends from random double-strand breaks. Large
blocks of telomere repeat sequences can be lost when these
end-capping proteins are disrupted, or problems are
encountered during DNA replication or repair (for review,
see Ref. 6). This typically results in p53- and Rb-mediated
senescence or cellular crisis, as evidenced by end-to-end
fusions of chromosomes, ATM-dependent activation of p53,
and apoptosis (for review, see Ref. 7).
Much has been learned about the properties of TRF1 and
TRF2 including their binding to DNA and the effects of their
ablation or overexpression in the cell. We observed that TRF1
forms filamentous structures on long tracts of telomeric DNA
in vitro (8), whereas TRF2 binds preferentially to the telomeric
DNA at the junction between the duplex repeats and the ss
overhang (9). Both TRF1 and TRF2 contain a similar Myb
domain at their COOH terminus thatmediates their binding to
ds telomeric DNA (10). TRF1 and TRF2 differ in their NH2
termini, however, which are rich in either acidic residues in
TRF1 or basic residues in TRF2. The function of the basic
domain of TRF2 is poorly understood. Deletion of this domain
(TRF2B) does not impede theDNAbinding activity of TRF2 or
its localization to telomeres in vivo, but expression of TRF2B
resulted in stochastic deletions of telomeric DNA, generation
of t-loop-sized telomeric circles, cell cycle arrest, and induction
of senescence in human cells (11, 12). In addition, recent evi-
dence suggested that the basic domain, but not the Myb
domain, was required forTRF2 associationwith photo-induced
double-strand breaks in non-telomeric DNA in human fibro-
blasts (13).
Relatively little is known about the replication ofmammalian
telomeric DNA in vivo; however, experiments in ciliates and
budding yeast have provided insight into how this occurs in
other eukaryotes. During each round of replication, all but the
very end of the telomere is replicated by the conventional semi
conservative polymerase machinery (14). Leading strand
sequences eroded in the last round of replication (end replica-
tion problem) can be restored by the reverse transcriptase
telomerase (15), whereas the lagging strand is concurrently
elongated by polymerases  and  using the newly formed G
strand as the template (16).
A possible complication of replication at the telomere is the
requirement for protecting the DNA ends from recognition by
DNArepair factorswhile still allowing theDNA to be accessible
to the replication machinery. Also, replication of telomeric
DNA tends to stall in vitro (17), and long blocks of telomeric
repeats are highly unstable when transformed into Escherichia
coli cells that lack recombination enzymes, suggesting difficul-
ties with DNA replication through the telomeric tract.3 Fur-
thermore, theG-rich strand of telomericDNAhas the tendency
to form G-quartets (18), and the complementary cytosine-rich
strand can fold into an intercalated tetramer called the i-motif
(19).
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The fact that human telomeres are replicated as rapidly as the
bulk DNA (20) suggests that in addition to the standard repli-
cative machinery, telomere-targeted factors may exist to
actively facilitate its rapid replication. Direct evidence for the
requirement of such telomeric factors at the replication fork
was recently discovered in the fission yeast Schizosaccharomy-
ces pombe, where the telomere-binding protein Taz1 is
required for efficient replication of telomeres (21). Also, in
addition to the normal replicative helicases present at forks, the
RecQ helicases WRN and BLM, implicated in premature aging
diseases, have been shown to be important for proper telomere
replication and maintenance in human cells (22–24).
The RecQ helicases have been shown to unwind G quartets
(25) and promote branch migration of four-stranded junctions
similar to chickenfoot structures (26, 27). In human cells TRF2
co-localizes and physically interacts with WRN (28), and it
binds to and stimulates the activities of both theWRNandBLM
helicases in vitro (29). TRF1 and POT1 have also been shown to
regulate WRN and BLM unwinding of telomeric substrates in
vitro (30, 31). Furthermore, in vitro overexpression of TRF1 and
TRF2 led directly to replication fork stalling (17), suggesting
that the telomere binding factors also have a direct effect on the
replication machinery.
We recently discovered a new feature of telomeric DNA that
may explain this requirement for the RecQ helicases during
telomere replication. Using electron microscopy (EM) and
model replication fork templates that mimic a replication fork
that had transited a long block of telomeric repeats, we discov-
ered that telomeric DNA is inherently more slippery than non-
repeat-containing DNA, such that the replication forks are able
tomore easily transition back and forth between non-regressed
and fully regressed states (1). During replication, repeat-con-
taining DNA could, therefore, spend a significantly larger frac-
tion of time in the partially regressed state, characterized by a
Holliday junction or “chickenfoot” structure, than other DNAs.
We believe that this presents a significant problem to the cell,
where these four-stranded structures could result in recruit-
ment of unwanted recombination factors or lead to deleterious
recombination events if repaired. p53 will also bind to stalled
chickenfoot structures with great affinity, suggesting that it
may have the ability to halt excessive fork regression (32). These
observations led us to askwhether one or both of the primary ds
telomere-binding proteins TRF1 and TRF2 might also show
some unusual binding with regard to three- and four-way DNA
junctions when they occur within telomeric tracts.
To test this hypothesis we generated a set of DNA templates
including telomeric and non-telomeric replication forks, Holli-
day junctions, and model telomeres containing 3 overhangs.
Using EM and polyacrylamide gel-shift assays, we evaluated
binding to these templates by TRF1, TRF2, and TRF2B as well
as a peptide encompassing the basic domain of TRF2 and
another similar “mutant” peptide containing a rearrangement
of four amino acids (aa).
In this paper we show that TRF2, but not TRF1 or TRF2B, is
able to target the junctions of replication forks, chickenfoot
structures, and Holliday junctions. Junction binding occurred
irrespective of the presence of TTAGGG repeats, and a bias for
four-stranded junctions was detected. The peptide mimicking
the basic domain of TRF2 recapitulated this four-way junction
binding, whereas the mutant peptide could not. Furthermore,
in the absence of other telomere-binding proteins, TRF2 lack-
ing the basic domain had a reduced ability to target the end of
the large model telomeres and facilitate t-loop formation in
vitro. We, therefore, suggest a novel role for the previously
uncharacterized basic domain of TRF2, which is to facilitate
TRF2 binding to chickenfoot intermediates of telomere repli-
cation fork regression, presumably preventing their recogni-
tion by Holliday junction resolvases. The data are also the first
direct demonstration of TRF2 binding to DNA junctions, irre-
spective of the presence of telomeric repeats.
EXPERIMENTAL PROCEDURES
DNA Probes and Templates—[-32P]ATP end-labeled J12
four-way junction probes (33), large Holliday-junction DNA
templates (HJ575 (34)), model non-telomeric replication forks
(32), andmodel telomere DNA (9) were synthesized as previously
described. A telomeric probe with a 14-nucleotide overhang was
prepared by annealing the [-32P]ATP end-labeled oligonucleo-
tide (oligo) 5-CTAACCCTAACCCTGTCCTAGCAATGTAA-
TCGTCTATGAGTCTG-3 to the oligo 5-CAGACTCATAGA-
CGATTACATTGCTAGGACAGGGTTAGGGTTAGGGTTA-
GGGTTAGGG-3. A hairpin probe consisting of a 7-nucleotide
linker and a 21-bp stem was prepared by heating and stepwise
cooling the [-32P]ATPend-labeledoligo5-CTTATTCACAGA-
CCACGACTCAAAAAAAGAGTCGTGGTCTGTGAATAAG-
3. All annealed products were purified on 10% nondenaturing
polyacrylamide gels.
Telomeric replication forks were created using a variant of
pRST5 (9) containing a nicking site directly adjacent to the
telomeric repeat tract (1). The plasmidwas nickedwithN.BbvC
IA (New England Biolabs, Ipswich, MA) and then incubated
with the Klenow fragment (exo) of DNA polymerase 1 (New
EnglandBiolabs) and 0.5mMeach of dTTP, dATP, anddGTP to
generate an ss tail by strand displacement of the repeat tract.
The ss tail was converted to a ds tail by annealing a 228-fold
molar excess of the oligo 5-CCCTAACCCTAACCCTAACC-
CTAA-3 to the template for 30 min at 37 °C in 100 mM NaCl
and ligating with T4 DNA ligase (400 units, New England Bio-
labs) at 16 °C overnight in 50 mM NaCl, 10 mM Tris-HCl (pH
7.9), and 1 mM dithiothreitol. When required, the replication
templates were linearized with XmnI (New England Biolabs)
for 1 h at 37 °C.
Proteins and Peptides—NH2-terminal His6-tagged human
TRF1, TRF2, and TRF2B were purified to homogeneity from
baculovirus-infected insect cells by themethod of Bianchi et al.
(35) except that a TalonTM metal affinity resin (Clontech, Palo
Alto, CA) was employed instead of nickel-nitrilotriacetic acid
(35). p53 as well as the carboxyl-terminal domain of the p53
protein comprising amino acid residues 311–393 were purified
as previously described (36).
Two peptides, each containing an NH2-terminal biotin
motif, were synthesized by the UNC Micro-Protein Facility,
University of North Carolina School of Medicine, Chapel Hill,
NC (Fig. 1B). The first peptide (Peptide_B) consisted of aa 2–31
of wild type human TRF2 (10), whereas the second peptide
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(Peptide_M) comprised a 4-aa sequence rearrangement of the
first peptide.
ElectronMicroscopy—Binding assays of TRF2 andTRF2B to
the model telomere were done as previously described (9).
Complexes of p53, TRF1, TRF2, TRF2B, and both peptides
withHolliday junction or replication fork DNAwere formed by
incubating a 25:1 molar ratio of protein monomer:DNA in a
20-l volume of EM buffer (20 mM HEPES (pH 7.5), 0.1 mM
EDTA, 0.5 mM dithiothreitol, 75 mM KCl) for 20 min at room
temperature. A 5 molar excess of streptavidin (Molecular
Probes, Eugene, OR) to peptide was added to samples contain-
ing biotin-tagged peptide for 5 min at room temperature. Sam-
ples were fixed with 0.6% (w/v) glutaraldehyde for 5 min at
room temperature followed by filtration through 2-ml columns
of 2% agarose beads (50–150 m, Agarose Bead Technologies,
Tampa, FL) pre-equilibrated with 0.01 M Tris-HCl (pH 7.6), 0.1
mM EDTA. The purified samples were prepared for EM by
rotary shadow-casting with tungsten as previously described
(37). An FEI Tecnai 12 electron microscope equipped with a
Gatan ultrascan camera (model US4000SP) were used to pho-
tograph images.
Mobility Shift Assays—Reaction mixtures (10 l) containing
probes (10 nM) and the proteins (see legends to Figs. 3 and 5 for
details) were incubated at room temperature for 20 min in EM
buffer. The mixtures were adjusted to 10% glycerol and loaded
on 3.5% non-denaturing polyacrylamide gels in 45 mM Tris
borate, 1 mM EDTA. The gels were run at 140 V for 1 h at 4 °C,
dried, analyzed by autoradiography, and quantified using a
Storm 840 PhosphorImager (GE Healthcare).
Calculating Kd—GraphPad Prism (GraphPad Software, Inc.,
San Diego, CA) was used for nonlinear regression of the data
obtained from themobility shift assays. The one-site hyperbolic
binding equation used was % probe shifted  (Bmax  [nM pro-
tein])/([nM protein]  Kd). In experiments with the Holliday
junction probe, dissociation constant (Kd) values were con-
verted to association constant (Ka) values (Ka  1/Kd) then
multiplied by the EM-specific binding factor (see “Results”)
(Ka,apparentKa%EMjunctionbinding) andagainconverted to
a dissociation constant (Kd,apparent  1/Ka,apparent (nM)).
RESULTS
To examine the binding of TRF1 and TRF2 to replication forks
and Holliday junctions and to compare this with previous studies
of p53 (32), a series of largemodel templates were constructed for
EM.Previouslywedescribed the generationof amodel replication
fork consisting of an 500-bp arm extended from a 3-kilobase
linear or circular DNA at a unique site, which is at the end of a
500-bp cassette consisting of a random but G-less sequence (32).
We constructed a new replication fork template based on this
design fromaplasmid containing a 560-bp telomeric cassette (Fig.
1A). In this DNA two arms of the Y-fork molecule contain
telomere repeats leading up to the fork junction. In addition, a
Holliday junction template containing 500-bp arms of plasmid-
derivedDNAextended from thewell known J12 junctionwas pre-
pared as previously described (33).
Purified TRF1 and TRF2 were incubated with the template
DNAs and prepared for EM. EM binding experiments were
conducted in parallel with purified p53. For these studies p53
was chosen for comparison with TRF2 not in an effort to argue
for the biological relevance if its binding to replication forks or
Holliday junctions but, rather, that it is of similar size to TRF2,
it binds these junctions tightly without altering their structure
significantly, and we have on hand data of p53 binding to the
very DNA templates used in this study. Examination of fields of
molecules from incubations of TRF2 with the model telomere
replication fork revealed several DNA-protein configurations.
When a 25:1 molar ratio of TRF2 monomers to DNA template
was used, approximately one-third of all molecules contained a
particle of TRF2 bound at the center of the stalled fork junction
(Fig. 2A). Of these molecules, a subset of the forks had
regressed, generating chickenfoot structures, and TRF2 was
also observed bound at these junctions (inset, Fig. 2A). The
remainder of the DNA consisted of DNA templates with no
protein bound (the majority), a fewer number of DNAs con-
taining TRF2 protein bound elsewhere on the DNA template
but not at the fork junction, and more frequently, aggregates of
two or more DNAs bound by a large mass of TRF2 (data not
shown). These aggregates became more abundant in binding
preparations containing molar ratios of TRF2 monomers to
DNA template greater than 25:1. Of the TRF2-bound mole-
cules where TRF2 was not located at the fork junction, the
majority had TRF2 bound sufficiently close to the fork that we
presumed it was bound along the TTAGGG tracts. Quantifica-
tion of the results from scoring hundreds of molecules is
described below. Although the TRF2 particles varied in size, in
most cases the size rangewasmuch less variable when bound to
the center of the three- or four-way junction than in the
FIGURE 1. DNA, protein, and peptide constructs used in this study. A, telo-
meric replication fork template and chickenfoot structure; the patterned
region indicates TTAGGG repeats. B, TRF1 and TRF2 have similar TRF
homodimerization (TRFH) and Myb DNA-binding domains. TRF2 has a unique
NH2-terminal basic domain (B, aa 13–30) with conserved residues (indicated
by an asterisk). TRF2B is a deletion mutant of TRF2 lacking the first 44 aa. The
basic (Peptide_B) and mutant (Peptide_M) peptides have an NH2-terminal
biotin moiety (bt), and they differ in their sequences (gray lettering) by a re-ar-
rangement of four aa (black lettering). hTRF, human TRF.
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instances when TRF2 was observed bound along the duplex
TTAGGG tracts (Fig. 2A, inset), and the particle size was sug-
gestive of TRF2 dimers or tetramers. When parallel experi-
ments were performed with TRF1, the telomeric repeats were
complexed by multiple protein particles (Fig. 2B) resembling
the TRF1 filaments formed along duplex TTAGGG tracts as
previously described (8).
For comparison, TRF1 and TRF2 were incubated with the
random sequence replication fork template lacking TTAGGG
repeats. The binding of TRF1 to this template was low (quanti-
fied in Fig. 3A), as expected from the lack of telomeric repeats.
Of great interest, however, was the observation that incubation
of TRF2 with this template led to discrete TRF2 complexes at
the three- or four-way junctions (Fig. 2C). In molecules in
which the forks had regressed into four-way chickenfoot forms,
TRF2 complexes were more frequently observed bound to the
DNA and almost always at the four-way junction (inset, Fig. 2C
and quantified below). This led us to examine TRF2 binding to
Holliday junction DNA containing 500-bp arms (Fig. 2D).
Indeed, by EM we found that TRF2 bound well to these struc-
tures, localizing to the center of the four-way junction. By com-
parison, TRF1 bound less well to these structures, and when it
did, the binding appeared to be random (quantified in Fig. 3B).
We previously examined the binding of p53 to random
sequencereplication fork templates (32)aswell as to largeHolliday
junction templates (33). We were, thus, able to combine these
results in a comparison of TRF1 and TRF2 binding to these tem-
plates (Fig. 3,A–C). An average of 179molecules over three exper-
iments was counted per experimental condition.
Incubation of p53 (25:1) with the telomeric replication fork
template resulted in observation of p53 at the fork and the fre-
quency (69  3 versus 8  1% elsewhere on the DNA; Fig. 3A)
was comparable with previous observations with non-telo-
meric forks (56% at the fork versus 15% bound elsewhere (32)).
We could not assess TRF1 binding to telomeric replication fork
templates because of its extensive binding to the telomeric
tract. Also, because the number of DNA molecules contained
within the TRF2 aggregates could not be determined by EM,
they were not included in the total number of DNAs counted.
Thus, the actual level of TRF2 binding to the telomeric replica-
tion fork is likely to be higher than the value cited here (34 21
versus 6  2% elsewhere on the DNA; Fig. 3A) because the
values were calculated as the percentage of the individual (non-
aggregated) DNAs only. The relatively wide spread in calcu-
lated TRF2 binding ismost likely due to a variation in the abun-
dance of TRF2 aggregates in these samples, becausewhenTRF2
binding in these samples was evaluated as a percentage of indi-
vidually boundmolecules, the S.D. was small (76 5% bound at
the junction versus 24  5% bound elsewhere).
A greater bias for the DNA junction was revealed for TRF2
binding to non-telomeric replication forks, where protein-
DNA aggregates were less abundant, and TRF2 bound to the
fork junction 48  6% of the time and elsewhere on the DNA
only 5 3%of the time. This was in contrast toTRF1 binding to
the non-telomeric replication forks, whichwas lower and seem-
ingly random; only 6 1% ofmolecules had TRF1 bound at the
fork junction, whereas 13  5% had TRF1 bound somewhere
else on the DNA.
TRF2 bound well to the Holliday junction templates, target-
ing the center of the 4-way junctions 75  5% of the time and
binding elsewhere on theDNAonly 8 4%of the time (Fig. 3B).
Previously, when p53 binding toHolliday junctions was studied
by EM, 59% of all molecules were bound at their center by p53
(33). When TRF1 binding to the Holliday junction templates
was examined, we found that it bound less well (18 6% bound
at the junction) than TRF2 and that most binding occurred on
one or more of the arms of the Holliday junction rather than at
the DNA junction (27  5%).
When binding to non-telomeric replication forks was exam-
ined in more detail it became apparent that TRF2 has a greater
affinity for the four-stranded replication fork structures (Fig.
3C). Specifically, we considered TRF2 binding to the Y-shaped
three-way junctions as a fraction of all three-stranded junctions
and, similarly, TRF2 binding to the chickenfoot four-way junc-
tions as a fraction of all four-way junctions. A bias was observed
where TRF2 bound to 89  4% of all 4-way junctions versus
36  11% of all 3-way junctions.When the DNA template con-
tained telomeric repeats, this preference was not as obvious
(42  3% of all 4-way junctions versus 13  4% of all 3-way
junctions), suggesting that the sequence-specific binding of
TRF2 to the surrounding sequences led to the apparent lower
fractional localization to the fork. p53 showed a smaller bias for
chickenfoot structureswhen bound to the telomeric replication
fork (82 1%of all 4-way junctions versus 59 10%of all 3-way
junctions) and no bias when binding to non-telomeric replica-
tion forks (52 8%of all 4-way junctions versus 52 7%of all
3-way junctions (32)). Collectively, these data suggest, there-
fore, that TRF2 has an affinity forDNA junctions, with a bias for
four-stranded DNA junctions resembling Holliday junctions.
To further examine the binding of these proteins to fork
junctions, mobility shift assays were carried out using TRF2,
FIGURE 2. TRF2 binds DNA junctions in vitro. A and C, discrete complexes of
TRF2 bound to the junctions of the three-stranded replication forks and the
four-stranded chickenfoot structures (arrow, inset) (A, telomeric template;
C, non-telomeric template). B, extensive, filamentous binding of TRF1 to a
model telomeric replication forks. D, TRF2 bound to the center of Holliday
junction template DNAs. The bar is equivalent to 450 bp in the panels show-
ing full-length molecules.
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TRF1, p53, and the 82-aa COOH-terminal fragment of p53
with a 100-bp -32P end-labeled Holliday junction probe (Fig.
3D). TRF2 shifted theHolliday junction probe equally as well as
p53, confirming our EM results. In contrast, approximately
four times as much TRF1 was required to observe any shift of
the probe, suggesting that this interaction with the Holliday
junction probemay be nonspecific for the DNA strands (as was
visualized by EM). As a control, we duplicated these binding
assays with a small -32P end-labeled hairpin probe, and in this
case neither TRF1 nor TRF2 was able to bind to and shift the
probe (data not shown).
These results suggest that TRF2 and p53 share common fea-
tures in binding to three-way and in particular four-way junc-
tions in a non-sequence-specific manner. This activity resides
in the COOH-terminal basic domain of p53. To determine
whether the basic domain ofTRF2 is involved in targetingTRF2
to DNA junctions, we purified an NH2-terminal deletion
mutant of TRF2 lacking the TRF2-specific basic domain
(TRF2B, Fig. 1B). We also had a peptide synthesized (Pep-
tide_B, Fig. 1B) that consisted of the amino acid sequence from
aa 2–31 of TRF2 and, thus, encompassed the basic domain (aa
13–31) of TRF2. In addition, we had a mutant peptide synthe-
sized (Peptide_M, Fig. 1B) comprising the same number and
composition of amino acids as Peptide_B such that the overall
positive charge of both peptides was the same but containing a
rearrangement of four amino acids,
twoofwhichwere conserved among
the species Gallus gallus (Chicken),
Muntiacus reevesi (Chinese munt-
jak), Muntiacus muntjak vaginalis
(Muntjak), Mus musculus (Mouse),
andHomo sapiens (human) (homol-
ogous vertebrate genes data base,
HOVERGEN).
EM binding experiments were
conductedwith these proteins using
the same conditions as used for
TRF2 and TRF1, except that
streptavidin was added to each of
the peptide-containing samples just
before sample preparation for EM.
Both peptides contained an NH2-
terminal biotin moiety to which
streptavidin could bind, thereby
increasing the overall molecular
weight of the peptides from 3 to 56
kDa (equivalent to a monomer of
TRF2 of 55 kDa) and allowing them
to be visualized by EM.
In experiments examining TRF2B
binding to telomeric replication fork
templates, the large majority of
molecules consisted of aggregates
of two or more DNAs bound by a
large mass of TRF2B protein,
although in some cases individual
molecules of DNA could be seen.
Frequently, these individual DNAs
contained long arrays or masses of bound TRF2B, although
less often we were able to visualize a discrete particle of
TRF2B bound to the DNA (Fig. 4A). In such instances,
TRF2B was localized to the telomeric repeats (on the dis-
placed strand or within a distance equivalent to 500 bp from
the fork junction), but it was rarely observed bound to the
replication fork junction.We, therefore, conclude that theTRF2B
protein does not show a preference for binding to telomeric repli-
cation fork junctions rather binding to the telomeric repeats in a
manner similar to TRF1. However, we cannot rule out that the
aggregates of TRF2B that bound to two or more DNAs also
included junction-bound molecules or that this complicated pat-
tern of binding reflects a different mode of binding to the DNA
junctions rather than the absence of binding. Nevertheless,
because most of the TRF2B protein in the sample was contained
within the aggregates of TRF2B, we were not able to quantify
TRF2B binding to this template DNA.
We did not separately quantify binding of the peptides to the
telomeric replication fork templates. The peptides do not have
a telomere-repeat recognitionmotif and were observed to have
similar binding to these templates (Fig. 4B) as to the non-telo-
meric replication fork templates (Fig. 4C). In experiments con-
taining Peptide_B and the non-telomeric replication fork tem-
plate, 41  1% of all molecules consisted of a complex of
streptavidin and Peptide_B bound at the center of the stalled
FIGURE 3. TRF2 junction binding is biased toward four-way junctions. A, binding of p53, TRF2, and TRF1 to
the telomeric replication fork templates (tel. RF ) and the non-telomeric replication fork templates (non-tel. RF)
was visualized by EM and quantified. Percentages are calculated as a fraction of all replication forks counted
(three-way and four-way junctions combined). Only molecules with protein bound at the junction of the
replication fork or chickenfoot structure were considered junction-bound molecules. Data are repre-
sented as the mean  S.D. B, Holliday junction (HJ ) templates bound by TRF1 or TRF2 were similarly
quantified. C, percentages of TRF2 and p53 binding to replication forks are calculated as a fraction of mole-
cules with the same shape. D, mobility shift assay of the -32P-labeled J12 junction probe alone (lane 1) or
bound by p53 (at a molar ratio of 30:1 protein:probe, lane 2), TRF2 (25:1, lane 3; 50:1, lane 4), an 82-aa COOH-
terminal fragment of p53 containing the basic domain (81:1, lane 5), and TRF1 (50:1, lane 6; 101:1, lane 7 ).
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fork junction (Fig. 4C, non-telomeric replication fork with the
inset showing chickenfoot structure; see also Fig. 4E). Protein
bound elsewhere on the DNA templates 8 1% of the time. No
protein-bound complexes were seen in samples containing
DNA and streptavidin alone (data not shown). Intriguingly, the
mutant Peptide_Mdisplayed 30 5 and 35 6%binding to the
junction and DNA arms of the non-telomeric replication forks,
respectively. This reflects an increase in the overall binding
from 49% (Peptide_B) to 65% (Peptide_M), with a seemingly
small difference in junction binding (41 versus 30%, respectively)
between the two peptides. However,
when we examined the junction
binding in more detail, we noticed
that the mutant Peptide_M had
decreased binding to four-way junc-
tions with little change in binding to
three-way junctions (Fig. 4F). Spe-
cifically, when Peptide_B-bound
molecules were evaluated as a frac-
tion of the total DNA molecules
with the same shape, Peptide_B
bound to 94  9% of all 4-stranded
replication fork junctions versus
32  8% of all 3-stranded junctions.
In contrast, Peptide_M bound to
only 33  0% 4-stranded junctions
(a reduction in binding of 61%),
whereas it was still able to bind to
29  6% of the 3-stranded junctions
(a reduction in binding of only 3%).
Therefore, it appears that a rear-
rangement of two conserved amino
acids with two non-conserved
amino acids disrupted four-way
junction binding of the peptide,
mimicking the TRF2 basic domain
even though overall (nonspecific)
binding increased, and binding to
the three-way junctions remained
largely the same.
The TRF2 truncation mutant,
TRF2B, showed only 7  6% bind-
ing to the non-telomeric replication
fork junctions, preferring to bind
somewhere else on the template
26  6% of the time. Therefore, it
seems that the loss of the basic
domain in the truncated TRF2 con-
struct attenuated its ability to target
replication fork junctions, where
junction binding was reduced from
48 to 7%, and non-junction binding
was increased from 5 to 26% (com-
pare Figs. 3A and 4E).
These results were more pro-
nounced in EM experiments done
with the Holliday junction template
(Fig. 4D). Junction binding for the
Peptide_B,Peptide_M,andTRF2B constructswas6011, 64,
and 16  6%, respectively, and non-junction binding was 3  1,
22 3, and 12 6% respectively (Fig. 4E). Thus, TRF2 binding to
the center of Holliday junction templates was reduced by 59%
(from75%)when thebasic regionwas absent, andPeptide_Bbind-
ingwas reducedby56%(from60%) in themutantPeptide_Msam-
ples. All of these data suggest, therefore, that the junction binding
activity (specifically the four-way junction binding activity) of
TRF2 ismediatedby theNH2-terminal aminoacidscontaining the
basic domain.
FIGURE 4. The TRF2 basic terminus binds DNA junctions in vitro, whereas TRF2B protein does not.
A, TRF2B bound to the TTAGGG repeats of the telomeric replication fork template. B–D, discrete molecules of
streptavidin-bound Peptide_B at the junctions of the telomeric chickenfoot structure (A), the non-telomeric
replication fork (C) or chickenfoot structure (arrow, inset), and the Holliday junction template DNAs (D). The bar
is equivalent to 450 bp in the panels showing full-length molecules. E, binding of the TRF2 basic peptide
(Pep_B), the mutant peptide (Pep_M), and TRF2B to the non-telomeric replication fork templates (RF ), and the
Holliday junction templates (HJ ) was visualized by EM and quantified. Percentages are calculated as a fraction
of all molecules counted. Only molecules with protein bound at the replication fork junction or at the center of
the four strands of the Holliday junction were considered junction-bound molecules. F, percentages of the
basic peptide (Pep_B) and the mutant peptide (Pep_M) binding to non-telomeric replication forks are calcu-
lated as a fraction of molecules with the same shape. RF-3WJ, 3-way junctions; RF-4WJ, 4-way junctions. Data
are represented as the mean  S.D.
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To compare the proteins used in this study with respect to
Holliday junction binding,mobility shift assayswere performed
using a constant amount (10 nM) of the small Holliday junction
probe in each sample. The concentration was varied for each
protein in increasing increments until no more probe could be
shifted into the gel. Two examples of these experiments are
shown in Figs. 5, A and B. All experiments were performed a
minimum of three times, and averages were taken for each data
point. Binding isotherms were generated with % probe shifted
(y axis) as a function of protein concentration (x axis). In all
instances, nonlinear regression of the data using a one-site
hyperbolic binding equation gave a goodness of fit (R2)  0.9.
The apparent Kd values obtained were, therefore, 614 nM
(TRF2), 819 nM (TRF1), 1401 nM (TRF2B), 261 nM (Peptide_B),
and 1065 nM (Peptide_M) (Fig. 5C). These values may not
reflect the true differences in binding, however, because gel-
shift analysis does not distinguish junction binding from non-
specific dsDNA binding. We, therefore, adjusted the apparent
Kd values by the following “specific binding factors” (corre-
sponding to the % junction-specific binding observed for
each protein via EM): 93% (TRF2), 39% (TRF1), 57%
(TRF2B), 95% (Peptide_B), and 21% (Peptide_M). The
resultant Adjusted Kd values (Fig. 5C) clearly highlight the
junction binding of TRF2 (661 nM) sand the basic domain
peptide (275 nM) versus the more random binding of TRF1
(2100 nM), TRF2B (2458 nM), and the mutant peptide (5071
nM). Interestingly, the apparent Kd values for TRF1 and
TRF2B are very similar. This result is not surprising consid-
ering that both of these proteins have very similar Myb DNA
binding domains that would likely bind to non-telomeric
DNA with a similar nonspecific affinity.
To test the activity of the telomere-binding proteins under
the binding conditions used, the mobility shift binding assays
and nonlinear regressions of the data were duplicated using a
small -32P end-labeled telomeric probe. In all cases, the one-
site binding hyperbola again gave a decent fit (R2  0.91). Bind-
ing of all three proteins to the telomeric probe appeared to be
equally as good, with TRF1 binding slightly better than the rest
(Fig. 5C). Most interestingly, TRF2 and TRF2B had an almost
identical affinity for the telomere probe, suggesting that dele-
tion of the basic domain had not destabilized the TRF2 core
structure. Therefore, the lower junction binding seen in the
TRF2B constructs appear not to be a result of destabilization of
the Myb DNA binding domain. Moreover, under the experi-
mental conditions used, TRF2 appeared to have a slightly
smallerKdwhen binding to the Holliday junction probe than to
the telomeric probe, suggesting that the basic domain of TRF2
has a similar, if not greater, affinity for DNA four-way junctions
as the Myb domain has for the consensus telomeric sequence.
Thiswas not the case for TRF1 orTRF2B even before adjusting
the Kd values with the EM data. Also, the same mobility shift
assays were performed with streptavidin binding to the Holli-
day junction probe as well as all proteins binding to a small
single-stranded DNA probe. In both cases none of the probe
was shifted in the gels, indicating the absence of binding (Fig.
5A, lane 16, and data not shown).
To test the protein domain requirements for TRF2 being able
to facilitate t-loop formation in vitro, large model telomeres
were constructed from a 3.5-kilobase telomere repeat-contain-
ing vector such that 560 bpof telomeric repeatswere positioned
at the end of the linearized DNA. A 54-nucleotide overhang
consisting of the sequence TTAGGG9 was ligated onto the end
containing the telomere repeats, whereas the opposite end was
kept blunt. TRF2 and TRF2B were simultaneously incubated
with the DNA and prepared for EM (9).
TRF2 and TRF2B appeared to have the same activity and
overall affinity for the model telomeres, binding (at all posi-
tions) 73  11% (TRF2) and 68  15% (TRF2B) of the time,
respectively.However, we noticed a difference in the position of
each of these proteins on the model telomere template. In
experiments containing TRF2, when we considered protein-
bound molecules, 50  10% consisted of a particle of TRF2
bound at the end of the model telomere (Fig. 6, A and E), and
34  6% had TRF2 bound within 560 bp of the end of model
telomere (presumably within the telomeric repeats). Also
observed were molecules where it appeared that the ss over-
FIGURE 5. The basic domain of TRF2 is required for binding to four-way
junctions. A and B, mobility shift assays of the -32P-labeled J12 junction
probe alone (lanes 1) or bound by the basic peptide (A, lanes 2–9), the mutant
peptide (A, lanes 9 –15), streptavidin alone (A, lane 16); TRF2 (B, lanes 2– 8), and
TRF2B (B, lanes 9 –14). In samples containing peptide, the molar ratio of
streptavidin protein:peptide used was 5:1. C, apparent dissociation constants
(Kd) for TRF2, TRF1, TRF2
B, the basic peptide (Pep_B), and the mutant peptide
(Pep_M) binding to the small -32P end-labeled telomere probe or to the
-32P end-labeled Holliday junction probe (J12). The last lane (Adjusted Kd)
shows the apparent Kd values for Holliday junction binding adjusted by the
specific binding factors obtained via EM.
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hang had invaded the duplex repeat to form a t-loop. Thus,
12  5% of the total protein-bound DNAs consisted of t-loops
that had a molecule of TRF2 at the junction of the invasion site
(Fig. 6, B and C). TRF2B bound to the end of the model
telomere in 22  1% of the DNAs, within the telomere repeats
73 1% (Fig. 6D and inset), and at the junction of a t-loop 2.5
4% of the time. Aggregates of two ormoreDNAs bound by a large
mass of TRF2 or TRF2B were observed but not scored (data not
shown). Our results are, therefore, comparable with previous
experiments in our laboratory that were optimized for t-loop for-
mation,whereTRF2bound to t-loop junctions19%of the time (9).
We show, therefore, that the basic domain of TRF2 is involved in
t-loop formation onmodel telomere templates in vitro.
DISCUSSION
In this study we used EM and gel-shift assays to evaluate the
binding of several telomeric factors to an array of DNA tem-
plates.We found that TRF2 was able to bind to the junctions of
replication forks, chickenfoot structures, and Holliday junc-
tions, whereas this binding was sig-
nificantly lower for TRF1 and the
TRF2 truncation mutant, TRF2B.
TRF2 binding to the DNA junctions
did not depend on telomere se-
quences being present in the DNA,
suggesting that the binding was not
related to the telomere-specific Myb
domain.Also, a bias for four-stranded
junctions was observed, especially in
non-telomeric substrates, suggesting
that these are a major target of TRF2
structure-specific binding.
This raises the question as to
whether the three-stranded replica-
tion fork junctions that were bound
by TRF2 consist of only three DNA
strands or might also contain a
small extruded fourth (chickenfoot)
stem that was not detected by EM.
This would be more likely with the
telomeric template, where the fork
has a natural tendency to regress at
repetitive DNAs but is less of a con-
cernwith the non-repeat containing
replication forks, where spontane-
ous regression is infrequent and the
fraction of chickenfoot intermedi-
ates is much lower (1). Also, the
fraction of chickenfoot intermedi-
ates did not change when TRF2 was
added, suggesting that TRF2 was
not able to actively regress the fork
to produce more stable four-
stranded binding substrates (data
not shown). Thus, we believe that
TRF2 binds to both three-way and
four-way DNA junctions in vitro.
Of particular interest were the
different binding affinities of the two peptides used in this
study. The peptide encompassing the basic domain of TRF2
bound well to DNA junctions, with a higher affinity for four-
stranded chickenfoot structures than the three-stranded repli-
cation fork templates. In contrast, whereas the mutant peptide
had the same net charge and amino acid composition of the
TRF2 basic domain, binding to four-stranded DNA junctions
was greatly disrupted. Thus, the two amino acids, which we
rearranged in the mutant peptide and which are conserved
within the TRF2 basic domains of some mammals and birds,
appear to be important for TRF2 binding to four-way DNA
junctions. Although the mutant peptide showed some DNA
binding, this likely reflects an electrostatic interaction between
the positively charged peptide and negatively charged DNA.
The dissociation constants that were calculated for the
proteins binding to radiolabeled Holliday junction probes
reflected the stronger affinity of TRF2 and the basic peptide
for these templates than TRF1, TRF2B, and the mutant pep-
tide, which all had larger dissociation constants. Also, when
FIGURE 6. Diminished in vitro t-loop formation and telomere ss/ds junction binding by TRF2B. Binding of
TRF2 and TRF2B to the large model telomeres was visualized by EM and quantified. A–C, discrete complexes of
TRF2 bound to the ends of the model telomeres (A) or at the strand invasion sites of the t-loop (B and C ). D and
inset, TRF2B typically bound within the TTAGGG repeat tract but not at the ends of the model telomere. The
bar is equivalent to 450 bp in panels showing full-length molecules. E, percentages of molecules with protein
bound at the DNA end (end-bound), bound within 560 bp from the end (within TTAGGG), bound at the t-loop
invasion site (t-loops), or bound more than 560 bp from the DNA end (nonspecific) were calculated as a fraction
of all protein-bound molecules scored. Data are represented as mean  S.D.
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TRF2 binding to large model telomeres was examined by EM,
we found that in the absence of the basic domain (TRF2B) the
ability of TRF2 to target the end of the large model telomeres
was diminished as was its ability to facilitate t-loop formation.
In gel-shift assays with a small telomeric probe, TRF1, TRF2,
and TRF2B all shifted equally as well, with TRF2 and TRF2B
having an almost identical affinity for the telomere probe.
Hence, deleting the basic domain fromTRF2does not appear to
destabilize the Myb domain, which remained intact in the
mutant. The apparent Kd values also suggest that TRF2 DNA-
structure binding via the basic domain is equally as strong as
telomere-DNA binding via the Myb domain.
The ability of TRF2 to bind telomeric DNA in a sequence-
specific manner but to have structure-dependent recruitment
to the telomeric ds/ss junction aswell as a possible function that
is independent of its Myb-dependent binding is reminiscent of
the multiple DNA binding properties of p53. p53 has a
sequence-specific DNAbinding domain aswell as an additional
domain at its extreme COOH terminus shown to bind in a
sequence-nonspecific manner to a wide variety of DNA targets
(32, 33, 38). These targets include unusualDNA structures such
as the four-strandedDNAHolliday junction, the Y-shaped rep-
lication fork, and chickenfoot intermediates of fork regression.
Intriguingly, this structure-specific binding domain of p53 is
also characterized by basic residues, and it has the same length
and overall positive charge as the TRF2 basic domain. We,
therefore, consider p53 a good protein to use as a control for in
vitro binding to DNA junctions, although we do not suggest
that these data support a biological role for TRF2 binding to
Holliday junctions.
Rather, we infer a biological relevance for TRF2 binding to
junctions by considering the TRF2B phenotype previously
studied by Wang et al. (11). Deletion of the basic domain did
not impede the DNA binding activity of TRF2 nor its localiza-
tion to telomeres in vivo, yet massive losses of telomeric DNA
were seen, accompanied by the appearance of telomeric circles,
a DNA damage response, and induction of senescence. More-
over, cells expressing the same level of TRF2B as control cells
but with impaired function of XRCC3 protein did not show
telomere deletions. We have shown in our laboratory that
XRCC3 will bind to Holliday junctions as well as chickenfoot
structures in vitro in complex with Rad51C.4 These observa-
tions suggest that without the basic domain, TRF2 is unable to
protect complex DNA structures at the telomere, such as those
that have been seen at model telomere replication forks or the
junction structure at the t-loop, from being recognized and pro-
cessed by DNA repair proteins, including XRCC3. Nevertheless,
becauseTRF2B is still able to suppressnon-homologousend join-
ing events, we believe that the loss of junction binding ability does
not directly lead to telomere uncapping, characterized by de-pro-
tection and loss of the 3 overhang, as seen in cells expressing the
dominant-negative allele of TRF2 (TRF2BM) (12).
Based on these findings we suggest a dual role for the TRF2
basic domain at the telomere. The first role involves a critical
function during telomere replication in mammals similar to
that of Taz1 in the fission yeast (21). We propose that if repli-
cation at the telomere stalls because of an impediment to the
polymerase machinery, for instance a G-quartet in the
unwound G-rich strand, TRF2 would be able to recognize and
bind to the chickenfoot intermediates produced by fork regres-
sion, thereby preventing the activity of Holliday junction
resolvases. TRF2 can then recruit factors like the RecQ heli-
cases to unwind the chickenfoot structures, allowing replica-
tion to restart. Indeed, this may explain why TRF2 is able to
interact with and stimulate the RecQ helicases, known to be
important for proper telomere replication and maintenance in
human cells (28, 29). The second role for TRF2 involving the
basic domain would be a role for TRF2 in t-loop formation and
stabilization.We propose that the junction binding property of
the basic domain enhances the ability of TRF2, in conjunction
with other telomere-associated proteins, to target chromosome
ends and facilitate t-loop formation. Junction binding capacity
would also make it possible for TRF2 to contribute to the sta-
bility of the t-loop by binding to junctions formed at the strand
invasion site of the t-loop.
We previously observed that psoralen cross-linking stabi-
lized t-loop formation in vitro on DNAs with very short over-
hangs, suggesting that more than just the nucleotides of the ss
tail are inserted into the duplex to form theD-loop (9). Based on
our findings we would further suggest that the more energeti-
cally favorable structure at the strand invasion site is a four-way
junction (preferred by TRF2 to the three-way junction) formed
by branch migration of the invasion site. The data are also the
first direct demonstration of TRF2 binding specifically and
selectively to non-telomeric DNA in vitro and may explain the
ability of TRF2 to localize to sites of DNA damage in irradiated
human fibroblasts (13).
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